Recent

% | $
Quotes you view appear here for quick access.

Dyax Corp. (DYAX) Message Board

carvedolol 3 posts  |  Last Activity: Mar 18, 2015 10:57 AM Member since: Sep 22, 2012
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • carvedolol by carvedolol Mar 18, 2015 10:57 AM Flag

    Are Pharmacy Committees of Insurance cos. and HMO's even evaluating Afrezza, much less giving it a 'low Tier' rating??

  • carvedolol by carvedolol Mar 15, 2015 5:35 PM Flag

    FDA is requiring a 5-year clinical trial to assess long-term malignancy risk. In already completed trials, 2 patients (with heavy tobacco use) taking Afrezza developed lung cancer and in no comparators. After that, 2 more non-smokers developed lung cancer.
    Long-term pulmonary safety of inhaling insulin remains unknown.

  • carvedolol by carvedolol Mar 2, 2015 11:20 PM Flag

    From DYAX Website: 'Additionally, based on prior research which shows evidence that the kallikrein-kinin cascade may contribute to diseases beyond HAE, we are using the [p-Kal] assays to identify other potential PKM diseases. Current areas of interest include diabetic macular edema, inflammatory bowel disease and rheumatoid arthritis, among others.'

DYAX
16.20-0.05(-0.31%)Mar 26 4:00 PMEDT